A Study of LY900027 Given by Insulin Pump to Participants With Type 1 Diabetes Mellitus
Status:
Completed
Trial end date:
2020-07-14
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to learn more about a new formulation of insulin lispro
when given by an insulin pump to participants with type 1 diabetes mellitus. The study will
investigate how the body processes the drug and how the drug affects the body. Information
about side effects will be collected. The study will last from six to 12 weeks for each
participant.